For each eligible study, two authors (MM and AN) independently extracted data, which was then reviewed by a third author (JV) using a piloted spreadsheet, in accordance with Cochrane Collaboration guidelines ( Where relevant data were missing, attempts were made to contact corresponding authors
The STEP program trials with semaglutide (a GLP-1-only agonist) and the SURMOUNT trials with tirzepatide (dual GIP/GLP-1 agonist) represent the strongest weight loss efficacy data in the history of pharmacotherapy for obesity
Providers like Pure Med Spa Chicago offer telemedicine semaglutide options, allowing patients to consult with experts and receive prescriptions without visiting in person
Journal of Aerosol Medicine and Pulmonary Drug Delivery 28 (1), 5967 (2015)
Stamatopoulos, K., et al
But for a large number of patients, the medications fall short, fail entirely, or come with side effects that make long-term use impossible